Amira Isaac

Angiopoietin-2 as a predictor of fibrosis regression in chronic hepatitis C virus patients after direct-acting antiviral drugs

H. Rasmy, Amira Isaac, Tarek Maged El Sakaty, 2021, The Egyptian Journal of Internal Medicine.

Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

H. Rasmy, H. H. Kaisar, I. Ibrahim, 2021, Egyptian Liver Journal.

Soluble CD163 as a surrogate marker of fibrosis regression in chronic HCV patients receiving direct antiviral agents

Amira Isaac, Ahmed Mones, Wesam Wassfy, 2019, Egyptian Journal of Hematology and Bone Marrow Transplantation.

The effect of hepatitis C virologic clearance on cardiovascular disease biomarker lipoprotein-associated phospholipase A2 and its relation to serum lipids

E. Safwat, R. Mohamed, S. A. Ibrahim, 2021, Egyptian Liver Journal.

Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment

Ahmed G. Hassan, O. A. Ahmed, H. Rasmy, 2021, The Egyptian Journal of Internal Medicine.

Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study

Alaa Ibrahim, H. Badawy, I. Mohamed, 2021, The Egyptian Journal of Hospital Medicine.

Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients

Mohammed Attia, Marwa Hassan, Z. Ali-Eldin, 2022, Tumour virus research.

Plasma CD24 level as a promising prognostic biomarker of hepatocellular carcinoma

H. Rasmy, Amira Isaac, E. Awad, 2024, Egyptian Liver Journal.